OCT 08, 2016 05:16 PM PDT

Gut Microbes can Assist Chemotherapy Drugs

WRITTEN BY: Carmen Leitch
Humans have a symbiotic relationship with microorganisms, many of which reside in our gastrointestinal tract, and they can be highly beneficial to our health. New work, reported in the journal Immunity, has indicated that there are two species of bacteria in our gut that can activate cells of our immune system to increase the efficacy of a common anticancer therapeutic. 
 
Scanning electron micrograph of a human T cell / Credit: Wikipedia

The bacteria, Enterococcus hirae and Barnesiella intestinihominis, have a role in the activation of immune responses to cancer that involve T cells, which boosts the effects of a chemotherapy drug. The researchers found that the microbe-assisted immune response led to longer survival without additional cancer growth in patients with advanced lung and ovarian cancer that have been given chemo-immunotherapy.

"The anti-cancer drug's efficacy relies on a complex interplay between the microbiome of cancer patients and their ability to mount an efficient immune memory response against some bacteria of the gut microbiota," explained the co-senior author of the study, Mathias Chamaillard, Research Director of the Center for Infection and Immunity of Lille (Inserm/CNRS/Lille University/Institut Pasteur de Lille). "This paradigm opens the way to improve treatment design by either optimizing the use of antibiotics, or implementing supplementation with so-called oncomicrobiotics or their bioactive metabolites, to promote the efficacy of anti-cancer drugs."

Previous work has demonstrated that some gut microbes are able to encourage the growth of tumors, but some are protective against cancer. While in some cases intestinal bacteria can improve the impact of chemotherapy agents, the mechanism this process has remained unclear, as has the identity of the bacterial species that are able to do so. 
 
E. hirae restored the efficacy of CTX in antibiotics-treated mice, E. hirae and B. intestinihominis enhanced cognate anticancer immune responses, NOD2 receptors limit the bioactivity of E. hirae and B. intestinihominis / Credit: Immunity Daillère et al

This new research has shown that E. hirae and B. intestinihominis both work to orchestrate the effects of the chemotherapy drug cyclophosphamide, which is an immunosuppressant used to treat many different types of cancers. The abstract for the publication is shown in the image above. Mouse models were utilized to illustrate that after oral treatment with E. hirae, the antitumor T cell response was activated  in the spleen along with the direct lethal effects of cisplatin on a tumor, thus reducing tumor growth. A similar effect was shown in oral treatment of B. intestinihominis;  T cells infiltration of various mouse tumors was promoted.

To follow up on the results, the blood T cell responses of 38 patients with advanced lung and ovarian cancer and chemotherapy treatment were analyzed. The investigators learned that memory T cell immune responses specific to E. hirae and B. intestinihominis predicted progression-free survival - the amount of time that a patient lives has the disease, but without it getting worse, during and after treatment.

The researchers hope to identify the exact microbial metabolites or molecules impacting the immune system that can enhance the effects of cyclophosphamide. "Answering this question may provide a way to improve the survival of cyclophosphamide-treated cancer patients by supplementing them with bacterial-derived drugs instead of live microorganisms," Chamaillard concluded.

Sources: Eurekalert!/AAAS via Cell Press, Immunity
About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
OCT 22, 2019
Chemistry & Physics
OCT 22, 2019
Competition of Different Photosynthesis Mechanisms might Have Slowed Down Oxygenation of the Prehistoric Earth
Long before Earth became a hotbed for a diversity of life forms, its atmosphere had almost no oxygen. Thanks to the emergence of photosynthesis inside prim...
OCT 22, 2019
Genetics & Genomics
OCT 22, 2019
Studying Mice That Harbor the Bacteria That Cause Lyme Disease
Lyme disease is on the rise, and researchers are working to learn more about how it's transmitted....
OCT 22, 2019
Microbiology
OCT 22, 2019
Picturing a New Kind of Antibiotic
Scientists have deciphered the X-ray crystal structure of an enzyme that generates a unique broad spectrum antibiotic called obafluorin....
OCT 22, 2019
Genetics & Genomics
OCT 22, 2019
A Pathogen That Has Evolved to Spread in Hospitals
Clostridium difficile is the primary cause of infections that are acquired in hospital settings; it causes diarrhea and intestinal inflammation....
OCT 22, 2019
Genetics & Genomics
OCT 22, 2019
Gene Mutations Link Flu Infections and Heart Trouble
Sometimes people develop life-threatening heart complications when they're infected with the flu....
OCT 22, 2019
Microbiology
OCT 22, 2019
The Antimicrobial Power of Mucus is Revealed
We produce several liters of mucus every day to cover more than 200 square meters in the human body....
Loading Comments...